The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan

Biological Psychiatry

Volumn 75, Issue 5, 2014, Pages 351-360

  Jonas, Rachel K ^a   Montojo, Caroline A ^a,b   Bearden, Carrie E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Copy number variant; dopamine; neurodevelopment; pleiotropy; schizophrenia; velocardiofacial DiGeorge syndrome

Indexed keywords

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTISM; CHROMOSOME DELETION 22Q11; CLINICAL FEATURE; COPY NUMBER VARIATION; DIGEORGE SYNDROME; DOPAMINERGIC NEUROTRANSMISSION; ENDOPHENOTYPE; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MENTAL DISEASE; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEUROPSYCHIATRIC DISORDER; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; VELOCARDIOFACIAL SYNDROME;

COPY NUMBER VARIANT; DOPAMINE; NEURODEVELOPMENT; PLEIOTROPY; SCHIZOPHRENIA; VELOCARDIOFACIAL/DIGEORGE SYNDROME;

ANIMALS; BRAIN; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; DIGEORGE SYNDROME; DNA COPY NUMBER VARIATIONS; HUMANS; MENTAL DISORDERS; PHENOTYPE; UBIQUITIN-PROTEIN LIGASES;

EID: 84893733661     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.07.019     Document Type: Review

References (106)

1. L. Edelmann, R.K. Pandita, E. Spiteri, B. Funke, R. Goldberg, and N. Palanisamy et al. A common molecular basis for rearrangement disorders on chromosome 22q11 Hum Mol Genet 8 1999 1157 1167
2. L.J. Drew, G.W. Crabtree, S. Markx, K.L. Stark, F. Chaverneff, and X.u. Bin et al. The 22q11.2 microdeletion: Fifteen years of insights into the genetic and neural complexity of psychiatric disorders Int J Dev Neurosci 29 2011 259 281
3. K.C. Murphy Schizophrenia and velo-cardio-facial syndrome Lancet 359 2002 426 430
4. A.S. Bassett, E.W.C. Chow, and R. Weksberg Chromosomal abnormalities and schizophrenia Am J Med Genet 97 2000 45 51
5. T. Green, D. Gothelf, B. Glaser, M. Debbané, A. Frisch, and M. Kotler et al. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 Deletion) syndrome J Am Acad Child Adolesc Psychiatry 48 2009 1060 1068
6. M. Karayiorgou, T.J. Simon, and J.A. Gogos 22q11.2 microdeletions: Linking DNA structural variation to brain dysfunction and schizophrenia Nat Rev Neurosci 11 2010 402 416
7. A.S. Bassett, E.W.C. Chow, J. Husted, R. Weksberg, O. Caluseriu, G.D. Webb, and M.A. Gatzoulis Clinical features of 78 adults with 22q11 deletion syndrome Am J Med Genet A 138 2005 307 313
8. J.A. Vorstman, E.J. Breetvelt, K.I. Thode, E.W. Chow, and A.S. Bassett Expression of autism spectrum and schizophrenia in patients with a 22q11.2 deletion Schizophr Res 143 2013 55 59
9. D.W. Meechan, E.S. Tucker, T.M. Maynard, and A.S. LaMantia Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome Proc Natl Acad Sci U S A 106 2009 16434 16445
10. K. Momma Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome Am J Cardiol 105 2010 1617 1624
11. W. Briegel, and M. Cohen Chromosome 22q11 deletion syndrome and its relevance for child and adolescent psychiatry. An overview of etiology, physical symptoms, aspects of child development and psychiatric disorders [German] Z Kinder Jugendpsychiatr Psychother 32 2004 107 115
12. T. Arinami Analyses of the associations between the genes of 22q11 deletion syndrome and schizophrenia J Hum Genet 51 2006 1037 1045
13. K.C. Murphy, L.A. Jones, and M.J. Owen High rates of schizophrenia in adults with velo-cardio-facial syndrome Arch Gen Psychiatry 56 1999 940 945
14. K. Baker, and J. Vorstman Is there a core neuropsychiatric phenotype in 22q11.2 deletion syndrome? Curr Opin Neurol 25 2012 131 137
15. J. Sebat, D.L. Levy, and S.E. McCarthy Rare structural variants in schizophrenia: One disorder, multiple mutations; one mutation, multiple disorders Trends Genet 25 2009 528 535
16. K.M. Antshel, K. Hendricks, R. Shprintzen, W. Fremont, A.M. Higgins, S.V. Faraone, and W.R. Kates The longitudinal course of attention deficit/hyperactivity disorder in velo-cardio-facial syndrome J Pediatr 163 2013 187 193
17. M. Debbané, B. Glaser, M.K. David, C. Feinstein, and S. Eliez Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: Neuropsychological and behavioral implications Schizophr Res 84 2006 187 193
18. J. Vorstman, M.E. Morcus, S.N. Duijff, P.W. Klaassen, J.A.H. Boer, and F.A. Beemer et al. The 22q11.2 deletion in children: High rate of autistic disorders and early onset of psychotic symptoms J Am Acad Child Adolesc Psychiatry 45 2006 1104 1113
19. M.-C. Whyte, C. Brett, L.K. Harrison, M. Byrne, P. Miller, S.M. Lawrie, and E.C. Johnstone Neuropsychological performance over time in people at high risk of developing schizophrenia and controls Biol Psychiatry 59 2006 730 739
20. A. Reichenberg, A. Caspi, H. Harrington, R. Houts, R.S.E. Keefe, and R.M. Murray et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: A 30-year study Am J Psychiatry 167 2010 160 169
21. W.R. Kates, K.M. Antshel, S.V. Faraone, W.P. Fremont, A.M. Higgins, and R.J. Shprintzen et al. Neuroanatomic predictors to prodromal psychosis in velocardiofacial syndrome (22q11.2 deletion syndrome): A longitudinal study Biol Psychiatry 69 2011 945 952
22. D. Gothelf, C. Feinstein, T. Thompson, E. Gu, L. Penniman, and E. Van Stone et al. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome Am J Psychiatry 164 2007 663 669
23. N.J. Butcher, E.W.C. Chow, G. Costain, D. Karas, A. Ho, and A.S. Bassett Functional outcomes of adults with 22q11.2 deletion syndrome Genet Med 14 2012 836 843
24. L.E. Krahn, D.M. Maraganore, and V.V. Michels Childhood-onset schizophrenia associated with parkinsonism in a patient with a microdeletion of chromosome 22 Mayo Clin Proc 73 1998 956 959
25. C. Zaleski, A.S. Bassett, K. Tam, A.L. Shugar, E.W.C. Chow, and E. McPherson The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome Am J Med Genet A 149 2009 525 528
26. A.E. Urban, J.O. Korbel, R. Selzer, T. Richmond, A. Hacker, and G.V. Popescu et al. High-resolution mapping of DNA copy alterations in human chromosome 22 using high-density tiling oligonucleotide arrays Proc Natl Acad Sci U S A 103 2006 4534 4539
27. C. Carlson, H. Sirotkin, R. Pandita, R. Goldberg, J. McKie, and R. Wadey et al. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients Am J Hum Genet 61 1997 620 629
28. M. Karayiorgou, M.A. Morris, B. Morrow, R.J. Shprintzen, R. Goldberg, and J. Borrow et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11 Proc Natl Acad Sci U S A 92 1995 7612 7616
29. M.C. Digilio, A. Angioni, M. De Santis, A. Lombardo, A. Giannotti, B. Dallapiccola, and B. Marino Spectrum of clinical variability in familial deletion 22q11.2: From full manifestation to extremely mild clinical anomalies Clin Genet 63 2003 308 313
30. C.M.B. Carvalho, F. Zhang, and J.R. Lupski Evolution in health and medicine Sackler colloquium: Genomic disorders: A window into human gene and genome evolution Proc Natl Acad Sci U S A 107 2010 1765 1771
31. T.H. Shaikh, H. Kurahashi, S.C. Saitta, A.M. O'Hare, P. Hu, and B.A. Roe et al. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: Genomic organization and deletion endpoint analysis Hum Mol Genet 9 2000 489 501
32. R. Sachidanandam, D. Weissman, S.C. Schmidt, J.M. Kakol, L.D. Stein, and G. Marth et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms Nature 409 2001 928 933
33. H.J. Cordell Epistasis: What it means, what it doesn't mean, and statistical methods to detect it in humans Hum Mol Genet 11 2002 2463 2468
34. K.L. Stark, B. Xu, A. Bagchi, W.-S. Lai, H. Liu, and R. Hsu et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model Nat Genet 40 2008 751 760
35. E. Hornstein, and N. Shomron Canalization of development by microRNAs Nat Genet 38 suppl 2006 S20 S24
36. S. Eliez, S.E. Antonarakis, M.A. Morris, S.P. Dahoun, and A.L. Reiss Parental origin of the deletion 22q11.2 and brain development in velocardiofacial syndrome: A preliminary study Arch Gen Psychiatry 58 2001 64 68
37. B. Glaser, D.L. Mumme, C. Blasey, M.A. Morris, S.P. Dahoun, and S.E. Antonarakis et al. Language skills in children with velocardiofacial syndrome (deletion 22q11.2) J Pediatr 140 2002 753 758
38. A.S. Bassett, C.R. Marshall, A.C. Lionel, E.W.C. Chow, and S.W. Scherer Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome Hum Mol Genet 17 2008 4045 4053
39. D. Riley, M. Wiznitzer, S. Schwartz, and A.B. Zinn A 13-year-old boy with cognitive impairment, retinoblastoma, and Wilson disease Neurology 57 2001 141 143
40. S. Ikegawa, H. Ohashi, F. Hosoda, Y. Fukushima, M. Ohki, and Y. Nakamura Pseudoachondroplasia with de novo deletion [del(11)(q21q22.2)] Am J Med Genet 77 1998 356 359
41. N. Liburd, M. Ghosh, S. Riazuddin, S. Naz, S. Khan, and Z. Ahmed et al. Novel mutations of MYO15A associated with profound deafness in consanguineous families and moderately severe hearing loss in a patient with Smith-Magenis syndrome Hum Genet 109 2001 535 541
42. M. Paterlini, S.S. Zakharenko, W.-S. Lai, J. Qin, H. Zhang, and J. Mukai et al. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice Nat Neurosci 8 2005 1586 1594
43. A. Bird DNA methylation patterns and epigenetic memory Genes Dev 16 2002 6 21
44. D. Gothelf, M. Schaer, and S. Eliez Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome Dev Disabil Res Revs 14 2008 59 68
45. G.M. Tan, D. Arnone, A.M. McIntosh, and K.P. Ebmeier Meta-analysis of magnetic resonance imaging studies in chromosome 22q11.2 deletion syndrome (velocardiofacial syndrome) Schizophr Res 115 2009 173 181
46. C.E. Bearden, T.G.M. van Erp, R.A. Dutton, A.D. Lee, T.J. Simon, and T.D. Cannon et al. Alterations in midline cortical thickness and gyrification patterns mapped in children with 22q11.2 deletions Cereb Cortex 19 2008 115 126
47. R. Toyoda, S. Assimacopoulos, J. Wilcoxon, A. Taylor, P. Feldman, and A. Suzuki-Hirano et al. FGF8 acts as a classic diffusible morphogen to pattern the neocortex Development 137 2010 3439 3448
48. W.R. Kates, C.P. Burnette, B.A. Bessette, B.S. Folley, L. Strunge, E.W. Jabs, and G.D. Pearlson Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2) J Child Neurol 19 2004 337 342
49. J.P. Bish, V. Nguyen, L. Ding, S. Ferrante, and T.J. Simon Thalamic reductions in children with chromosome 22q11.2 deletion syndrome Neuroreport 15 2004 1413 1415
50. K.M. Antshel, J. Conchelos, G. Lanzetta, W. Fremont, and W.R. Kates Behavior and corpus callosum morphology relationships in velocardiofacial syndrome (22q11.2 deletion syndrome) Psychiatry Res 138 2005 235 245
51. A.M.C. Machado, T.J. Simon, V. Nguyen, D.M. McDonald-McGinn, E.H. Zackai, and J.C. Gee Corpus callosum morphology and ventricular size in chromosome 22q11.2 deletion syndrome Brain Res 1131 2007 197 210
52. D.U. Frank, L.K. Fotheringham, J.A. Brewer, L.J. Muglia, M. Tristani-Firouzi, M.R. Capecchi, and A.M. Moon An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome Development 129 2002 4591 4603
53. D. Gothelf, F. Hoeft, C. Hinard, J.F. Hallmayer, J. Van Dover Stoecker, and S.E. Antonarakis et al. Abnormal cortical activation during response inhibition in 22q11.2 deletion syndrome Hum Brain Mapp 28 2007 533 542
54. R. Azuma, E.M. Daly, L.E. Campbell, A.F. Stevens, Q. Deeley, and V. Giampietro et al. Visuospatial working memory in children and adolescents with 22q11.2 deletion syndrome; an fMRI study J Neurodev Disord 1 2009 46 60
55. S.J. Broyd, C. Demanuele, S. Debener, S.K. Helps, C.J. James, and E.J.S. Sonuga-Barke Default-mode brain dysfunction in mental disorders: A systematic review Neurosci Biobehav Rev 33 2009 279 296
56. M. Debbané, M. Lazouret, A. Lagioia, M. Schneider, D. Van De Ville, and S. Eliez Resting-state networks in adolescents with 22q11.2 deletion syndrome: Associations with prodromal symptoms and executive functions Schizophr Res 139 2012 33 39
57. L. Kempf, K.K. Nicodemus, B. Kolachana, R. Vakkalanka, B.A. Verchinski, and M.F. Egan et al. Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function PLoS Genet 4 2008 e1000252
58. L.R. Earls, R.G. Fricke, J. Yu, R.B. Berry, L.T. Baldwin, and S.S. Zakharenko Age-dependent microRNA control of synaptic plasticity in 22q11 deletion syndrome and schizophrenia J Neurosci 32 2012 14132 14144
59. C.E. Bearden, M.F. Woodin, P.P. Wang, E. Moss, D. McDonald-McGinn, and E. Zackai et al. The neurocognitive phenotype of the 22q11.2 deletion syndrome: Selective deficit in visual-spatial memory J Clin Exp Neuropsychol 23 2001 447 464
60. A. Swillen, K. Devriendt, E. Legius, B. Eyskens, M. Dumoulin, M. Gewillig, and J.P. Fryns Intelligence and psychosocial adjustment in velocardiofacial syndrome: A study of 37 children and adolescents with VCFS J Med Genet 34 1997 453 458
61. N. Philip, and A. Bassett Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome Behav Genet 41 2011 403 412
62. D.B. Davalos, N. Compagnon, S. Heinlein, and R.G. Ross Neuropsychological deficits in children associated with increased familial risk for schizophrenia Schizophr Res 67 2004 123 130
63. K.M. Antshel, R. Shprintzen, W. Fremont, A.M. Higgins, S.V. Faraone, and W.R. Kates Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: A 3-year follow-up study J Am Acad Child Adolesc Psychiatry 49 2010 333 344
64. N. Baker, L.E. Adler, R.D. Franks, M. Waldo, S. Berry, and H. Nagamoto et al. Neurophysiological assessment of sensory gating in psychiatric inpatients: Comparison between schizophrenia and other diagnoses Biol Psychiatry 22 1987 603 617
65. C. Sobin Lower prepulse inhibition in children with the 22q11 deletion syndrome Am J Psychiatry 162 2005 1090 1099
66. T. Hiramoto, G. Kang, G. Suzuki, Y. Satoh, R. Kucherlapati, Y. Watanabe, and N. Hiroi Tbx1: Identification of a 22q11.2 gene as a risk factor for autism spectrum disorder in a mouse model Hum Mol Genet 20 2011 4775 4785
67. K.M. Harper, T. Hiramoto, K. Tanigaki, G. Kang, G. Suzuki, W. Trimble, and N. Hiroi Alterations of social interaction through genetic and environmental manipulation of the 22q11.2 gene Sept5 in the mouse brain Hum Mol Genet 21 2012 3489 3499
68. R. Paylor, B. Glaser, A. Mupo, P. Ataliotis, C. Spencer, and A. Sobotka et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome Proc Natl Acad Sci U S A 103 2006 7729 7734
69. O.D. Howes, J. Kambeitz, E. Kim, D. Stahl, M. Slifstein, A. Abi-Dargham, and S. Kapur The nature of dopamine dysfunction in schizophrenia and what this means for treatment Arch Gen Psychiatry 69 2012 776 786
70. H.M. Abdolmaleky, C.L. Smith, J.-R. Zhou, and S. Thiagalingam Epigenetic alterations of the dopaminergic system in major psychiatric disorders Methods Mol Biol 448 2008 187 212
71. L. Yavich, M.M. Forsberg, M. Karayiorgou, J.A. Gogos, and P.T. Mannistö Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum J Neurosci 27 2007 10196 10209
72. J. Chen, B.K. Lipska, N. Halim, Q.D. Ma, M. Matsumoto, and S. Melhem et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain Am J Hum Genet 75 2004 807 821
73. M.F. Egan, T.E. Goldberg, B.S. Kolachana, J.H. Callicott, C.M. Mazzanti, and R.E. Straub et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia Proc Natl Acad Sci U S A 98 2001 6917 6922
74. D.J. Stein, T.K. Newman, J. Savitz, and R. Ramesar Warriors versus worriers: The role of COMT gene variants CNS Spectr 11 2006 745 748
75. B.-C. Ho, T.H. Wassink, D.S. O'Leary, V.C. Sheffield, and N.C. Andreasen Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: Working memory, frontal lobe MRI morphology and frontal cerebral blood flow Mol Psychiatry 10 229 2005 287 298
76. D. Gothelf, S. Eliez, T. Thompson, C. Hinard, L. Penniman, and C. Feinstein et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome Nat Neurosci 8 2005 1500 1502
77. K.C. Murphy, L.A. Jones, and M.J. Owen High rates of schizophrenia in adults with velo-cardio-facial syndrome Arch Gen Psychiatry 56 1999 940 945
78. B. Glaser, M. Debbané, C. Hinard, M.A. Morris, S.P. Dahoun, S.E. Antonarakis, and S. Eliez No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome Am J Psychiatry 163 2006 537 539
79. V. Shashi, M. Keshavan, T. Howard, M. Berry, M. Basehore, E. Lewandowski, and T. Kwapil Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome Clin Genet 69 2006 234 238
80. K. Baker, T. Baldeweg, S. Sivagnanasundaram, P. Scambler, and D. Skuse COMT Val108/158Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome Biol Psychiatry 58 2005 23 31
81. D. Gothelf, S. Eliez, T. Thompson, C. Hinard, L. Penniman, and C. Feinstein et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome Nat Neurosci 8 2005 1500 1502
82. E. Boot, J. Booij, N. Abeling, J. Meijer, F. da Silva Alves, and J. Zinkstok et al. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia - relationship with COMT Val108/158 Met polymorphism, gender and symptomatology J Psychopharmacol 25 2011 888 895
83. 123I]IBZM SPECT study J Psychopharmacol 24 2010 1525 1531
84. M. Huotari, J.A. Gogos, M. Karayiorgou, O. Koponen, M. Forsberg, and A. Raasmaja et al. Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice Eur J Neurosci 15 2002 246 256
85. T. Li, X. Ma, X. Hu, Y. Wang, C. Yan, and H. Meng et al. PRODH gene is associated with executive function in schizophrenic families Am J Med Genet B Neuropsychiatr Genet 147B 2008 654 657
86. H. Jacquet PRODH mutations and hyperprolinemia in a subset of schizophrenic patients Hum Mol Genet 11 2002 2243 2249
87. M. Paterlini, S.S. Zakharenko, W.-S. Lai, J. Qin, H. Zhang, and J. Mukai et al. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice Nat Neurosci 8 2005 1586 1594
88. F. Papaleo, J.N. Crawley, J. Song, B.K. Lipska, J. Pickel, D.R. Weinberger, and J. Chen Genetic dissection of the role of catechol-O- methyltransferase in cognition and stress reactivity in mice J Neurosci 28 2008 8709 8723
89. J. Vorstman, B.I. Turetsky, M.E.J. Sijmens-Morcus, M.G. de Sain, B. Dorland, and M. Sprong et al. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele Neuropsychopharmacology 34 2009 739 746
90. M.J.C.M. Magnée, V.A.F. Lamme, M.G.M. de Sain-van der Velden, J.A.S. Vorstman, and C. Kemner Proline and COMT status affect visual connectivity in children with 22q11.2 deletion syndrome PLoS One 6 2011 e25882
91. C. Pantelis, D. Velakoulis, P.D. McGorry, S.J. Wood, J. Suckling, and L.J. Phillips et al. Neuroanatomical abnormalities before and after onset of psychosis: A cross-sectional and longitudinal MRI comparison Lancet 361 2003 281 288
92. A.J. Giuliano, H. Li, R.I. Mesholam-Gately, S.M. Sorenson, K.A. Woodberry, and L.J. Seidman Neurocognition in the psychosis risk syndrome: A quantitative and qualitative review Curr Pharm Des 18 2012 399 415
93. M. Jalbrzikowski, and C.E. Bearden Clinical and genetic high-risk paradigms: Converging paths to psychosis meet in the temporal lobes Biol Psychiatry 69 2011 910 911
94. A.S. Bassett, E.W.C. Chow, P. AbdelMalik, M. Gheorghiu, J. Husted, and R. Weksberg The schizophrenia phenotype in 22q11 deletion syndrome Am J Psychiatry 160 2003 1580 1586
95. S.N. Duijff, P.W.J. Klaassen, H.F.N.S. de Veye, F.A. Beemer, G. Sinnema, and J.A.S. Vorstman Cognitive development in children with 22q11.2 deletion syndrome Br J Psychiatry 200 2012 462 468
96. E.W.C. Chow, M. Watson, D.A. Young, and A.S. Bassett Neurocognitive profile in 22q11 deletion syndrome and schizophrenia Schizophr Res 87 2006 270 278
97. T. van Amelsvoort, J. Henry, R. Morris, M. Owen, D. Linszen, K. Murphy, and D. Murphy Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome Schizophr Res 70 2004 223 232
98. J.R. Geddes, and S.M. Lawrie Obstetric complications and schizophrenia: A meta-analysis Br J Psychiatry 167 1995 786 793
99. D.A. Schlosser, R. Pearson, V.B. Perez, and R.L. Loewy Environmental risk and protective factors and their influence on the emergence of psychosis Adolesc Psychiatry (Hilversum) 2 2012 163 171
100. E.A. Beaton, and T.J. Simon How might stress contribute to increased risk for schizophrenia in children with chromosome 22q11.2 deletion syndrome? J Neurodev Disord 3 2011 68 75
101. L.J. Seidman, A.J. Giuliano, E.C. Meyer, J. Addington, K.S. Cadenhead, and T.D. Cannon et al. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: Relationship to family history and conversion to psychosis Arch Gen Psychiatry 67 2010 578 588
102. T.H. Shaikh, R.J. O'Connor, M.E. Pierpont, J. McGrath, A.M. Hacker, and M. Nimmakayalu et al. Low copy repeats mediate distal chromosome 22q11.2 deletions: Sequence analysis predicts breakpoint mechanisms Genome Res 17 2007 482 491
103. L. Niklasson, P. Rasmussen, S. Oskarsdóttir, and C. Gillberg Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome Res Dev Disabil 30 2009 763 773
104. W.L.A. Fung, R. McEvilly, J. Fong, C. Silversides, E. Chow, and A. Bassett Elevated prevalence of generalized anxiety disorder in adults with 22q11.2 deletion syndrome Am J Psychiatry 167 2010 997 998
105. K. Fenelon, J. Mukai, B. Xu, P.-K. Hsu, L.J. Drew, and M. Karayiorgou et al. Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex Proc Natl Acad Sci U S A 108 2011 4447 4452
106. I.I. Gottesman, and T.D. Gould The endophenotype concept in psychiatry: Etymology and strategic intentions Am J Psychiatry 160 2003 636 645